<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00125294</url>
  </required_header>
  <id_info>
    <org_study_id>17208</org_study_id>
    <secondary_id>Calgary Health Region</secondary_id>
    <nct_id>NCT00125294</nct_id>
  </id_info>
  <brief_title>Sublingual Methadone for the Management of Cancer Breakthrough Pain</brief_title>
  <official_title>Evaluation of a Dose Titration Protocol for Sublingual Methadone Hydrochloride for the Management of Cancer-related Breakthrough Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AHS Cancer Control Alberta</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Calgary Health Region</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>AHS Cancer Control Alberta</source>
  <brief_summary>
    <textblock>
      A dose titration protocol for sublingual methadone hydrochloride for the management of
      cancer-related breakthrough pain to find the optimal dose.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a dose titration protocol for sublingual methadone hydrochloride for the management
      of cancer-related breakthrough pain to find the optimal dose.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2003</start_date>
  <completion_date type="Actual">January 2007</completion_date>
  <primary_completion_date type="Actual">June 2006</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Determine optimal dose titration</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Determine assessment protocol</measure>
  </primary_outcome>
  <enrollment type="Actual">10</enrollment>
  <condition>Cancer</condition>
  <condition>Pain</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Methadone</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  &gt; 18 years of age

          -  Experiences episodes of breakthrough pain which respond to opioid therapy

          -  Controlled baseline pain

          -  Cognitive status sufficient for accurate completion of assessment form

          -  Willing to provide written informed consent

          -  Ability to hold a volume of 1 cc of water under the tongue for 5 minutes

        Exclusion Criteria:

          -  Currently or has received methadone during the previous week

          -  Recent history of substance abuse

          -  Severe respiratory impairment or other contraindications to opioids

          -  Recently received therapies that had the potential to alter pain intensity or response
             to analgesics

          -  Symptomatic anemia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Neil Hagen</last_name>
    <role>Principal Investigator</role>
    <affiliation>Alberta Cancerboard</affiliation>
  </overall_official>
  <removed_countries>
    <country>Canada</country>
  </removed_countries>
  <verification_date>August 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 29, 2005</study_first_submitted>
  <study_first_submitted_qc>July 29, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 1, 2005</study_first_posted>
  <last_update_submitted>September 21, 2017</last_update_submitted>
  <last_update_submitted_qc>September 21, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 25, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cancer pain</keyword>
  <keyword>breakthrough pain</keyword>
  <keyword>methadone</keyword>
  <keyword>dose titration</keyword>
  <keyword>sublingual route of administration</keyword>
  <keyword>Cancer related pain</keyword>
  <keyword>currently taking narcotics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breakthrough Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Methadone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

